Click to Enlarge
Facebook
Twitter
The Financial Times leads on pharmaceuticals giant AstraZeneca drawing up plans to separate the Chinese arm of its global business and list it on the Hong Kong stock exchange – as a way of sheltering the company against mounting geopolitical tensions. The paper observes the moves shows the “significant restructuring” companies could be forced to undertake as they adapt to growing China–US friction. A person briefed on the plans explains to the paper it could insulate the firm from any moves by China to crackdown on foreign companies, by making it more plausibly a Chinese business.

Financial Times Front Page 4th of December 2025

Bond investors cautioned the US Treasury that selecting Kevin Hassett to replace Powell as Fed chair could unsettle markets, citing worries over his perceived political ties and potential for sweeping rate cuts. Officials said the selection process continues, with alternatives under review.

Read More »

Financial Times Front Page 3rd of December 2025

Nigel Farage told Reform donors he expects an arrangement with the Tories before the next election, possibly a merger or pact to avoid splitting the vote. Citing the fall‑out from 2019, he said past dealings will shape any terms. With an outright Reform win seen unlikely, a tie‑up could increase leverage over policy and seats.

Read More »

Financial Times Front Page 2nd of December 2025

OBR chair Richard Hughes has quit after a review concluded a Budget leak resulted from failings in the watchdog’s leadership, with a similar error at the Spring Statement. The episode heightens tension with the Treasury as ministers consider tightening OBR protocols.

Read More »